214 related articles for article (PubMed ID: 6289691)
1. [Current patholophysiologic and morphologic concepts of polycystic disease of the ovary].
Vulkov I; Georgiev Ch
Akush Ginekol (Sofiia); 1982; 21(3):238-43. PubMed ID: 6289691
[No Abstract] [Full Text] [Related]
2. Polycystic ovarian disease.
Goldzieher JW
Clin Obstet Gynecol; 1973 Dec; 16(4):82-105. PubMed ID: 4593954
[No Abstract] [Full Text] [Related]
3. [Clinical and biochemical aspects of the Stein-Leventhal polycystic ovary syndrome].
Salcedo CA; Gómez Rueda A
Rev Colomb Obstet Ginecol; 1967; 18(1):21-39. PubMed ID: 4882333
[No Abstract] [Full Text] [Related]
4. The androgenic polycystic ovary.
Greenblatt RB; Mahesh VB
Am J Obstet Gynecol; 1976 Jul; 125(5):712-26. PubMed ID: 180807
[TBL] [Abstract][Full Text] [Related]
5. Polycystic ovary syndrome.
Chihal HJ; Baudier MM
Am Fam Physician; 1985 Apr; 31(4):159-65. PubMed ID: 3157301
[TBL] [Abstract][Full Text] [Related]
6. [Etiopathogenesis of the polycystic ovary syndrome].
Sciarra F; Toscano V; Tosti-Croce C
Minerva Endocrinol; 1987; 12(3):183-90. PubMed ID: 3116379
[No Abstract] [Full Text] [Related]
7. Pathogenesis of polycystic ovarian disease.
James R; Givens MD
Acta Eur Fertil; 1979 Sep; 10(3):89-103. PubMed ID: 121017
[No Abstract] [Full Text] [Related]
8. Inappropriate secretion of LH in the Stein-Leventhal syndrome.
Gambrell RD; Greenblatt RB; Mahesh VB
Obstet Gynecol; 1973 Sep; 42(3):429-40. PubMed ID: 4724412
[No Abstract] [Full Text] [Related]
9. [Reaction of follicle-stimulating and luteinizing hormone to synthetic luteinizing hormone in the Stein-Leventhal syndrome].
Vulkov I
Akush Ginekol (Sofiia); 1976; 15(6):459-62. PubMed ID: 797267
[No Abstract] [Full Text] [Related]
10. [Endocrinological environment in polycystic ovarian disease (PCOD)].
Fujimoto S; Tanaka T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Sep; 40(9):1465-70. PubMed ID: 3049852
[No Abstract] [Full Text] [Related]
11. The polycystic ovary syndrome. 1. Pathogenesis.
White MC; Turner EI
Br J Hosp Med; 1994 Feb 16-Mar 1; 51(4):167-74. PubMed ID: 8012678
[TBL] [Abstract][Full Text] [Related]
12. Can polycystic ovary syndrome exist without concomitant hypothalamic dysfunction?
Berga SL; Daniels TL
Semin Reprod Endocrinol; 1997 May; 15(2):169-75. PubMed ID: 9165660
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovarian disease: current concepts of pathophysiology and therapy.
Coney P
Fertil Steril; 1984 Nov; 42(5):667-82. PubMed ID: 6237940
[No Abstract] [Full Text] [Related]
14. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
15. [Round-table discussion of Stein-Leventhal syndrome].
Rev Fr Endocrinol Clin; 1971; 12(3):199-217. PubMed ID: 5151209
[No Abstract] [Full Text] [Related]
16. The polycystic ovary syndrome.
Yen SS
Clin Endocrinol (Oxf); 1980 Feb; 12(2):177-207. PubMed ID: 6772357
[No Abstract] [Full Text] [Related]
17. Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty.
Blank SK; McCartney CR; Helm KD; Marshall JC
Semin Reprod Med; 2007 Sep; 25(5):352-9. PubMed ID: 17710731
[TBL] [Abstract][Full Text] [Related]
18. Clinical and endocrine characteristics of the main polycystic ovary syndrome phenotypes.
Guastella E; Longo RA; Carmina E
Fertil Steril; 2010 Nov; 94(6):2197-201. PubMed ID: 20303485
[TBL] [Abstract][Full Text] [Related]
19. Inappropriate secretion of follicle-stimulating hormone and luteinizing hormone in polycystic ovarian disease.
Yen SS; Vela P; Rankin J
J Clin Endocrinol Metab; 1970 Apr; 30(4):435-42. PubMed ID: 5435284
[No Abstract] [Full Text] [Related]
20. [Polycystic ovary syndrome].
Kitaoka Y; Takakura K; Mori T
Nihon Rinsho; 1993 Jan; 51 Suppl():172-81. PubMed ID: 8459542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
